BBC
Virtus Biotech Clinical Trials ETF
1W: -1.3%
1M: -17.1%
3M: -15.6%
YTD: +18.4%
1Y: +63.3%
3Y: +130.2%
5Y: -5.1%
$44.56
-0.44 (-0.98%)
Weekly Expected Move ±4.8%
$40
$42
$45
$47
$49
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
35.4
★★★★★
Altman Z-Score
25.58
Safe
Weight Coverage
96%
of portfolio analyzed
Holdings Matched
125
with fundamental data
InsiderStreet Scorecard
★★★★★
35.4
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
25.58
Safe Zone (>2.99)
Piotroski F-Score
2.9 / 9
Weak
Beneish M-Score
-74.30
Unlikely Manipulator
Credit Score
—
Earnings Quality
49.7 / 100
Portfolio Valuation
P/E
282.10x
P/B
5.44x
P/S
82.80x
EV/EBITDA
189.27x
EV/Revenue
78.99x
P/FCF
2556.16x
P/OCF
2389.13x
PEG
77.93x
Earnings Yield
0.35%
FCF Yield
0.04%
OCF Yield
0.04%
Median P/E
-6.63x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+46.1%
Net Income
-17.5%
EPS
+3.6%
FCF
-20.1%
EBITDA
-11.5%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+54.7%
Rev CAGR 5Y
+26.6%
EPS CAGR 3Y
—
EPS CAGR 5Y
—
FCF CAGR 3Y
—
FCF CAGR 5Y
+27.5%
EBITDA CAGR 3Y
—
EBITDA CAGR 5Y
—
Payout Ratio
0.00%
Buyback Yield
0.29%
Dividend Yield
0.00%
Total Shareholder Return
-27.94%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$44.56
Median 1Y
$44.40
5th Pctile
$24.10
95th Pctile
$81.93
Ann. Volatility
39.6%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 282.10 |
| Portfolio P/B | 5.44 |
| Portfolio P/S | 82.80 |
| EV/EBITDA | 189.27 |
| EV/Revenue | 78.99 |
| P/FCF | 2556.16 |
| P/OCF | 2389.13 |
| PEG | 77.93 |
| Earnings Yield | 0.35% |
| FCF Yield | 0.04% |
| OCF Yield | 0.04% |
| Median P/E | -6.63 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 92.99% |
| Operating Margin | -683.60% |
| Net Margin | -629.31% |
| FCF Margin | -672.83% |
| ROE | -46.77% |
| ROA | -36.15% |
| ROIC | -183.87% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.12 |
| Debt/Assets | 0.09 |
| Net Debt/EBITDA | -31.89 |
| Interest Coverage | -43.73 |
| Current Ratio | 9.42 |
| Quick Ratio | 9.42 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 46.08% |
| Net Income Growth | -17.51% |
| EPS Growth | 3.62% |
| FCF Growth | -20.11% |
| EBITDA Growth | -11.46% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 54.68% |
| Revenue CAGR 5Y | 26.64% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | — |
| EPS CAGR 5Y | — |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | — |
| FCF CAGR 5Y | 27.45% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | — |
| EBITDA CAGR 5Y | — |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | — |
| Net Income CAGR 5Y | — |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 35.4 |
| IS Profitability | 24.6 |
| IS Balance Sheet | 56.8 |
| IS Earnings Quality | 49.7 |
| IS Growth | 50.5 |
| IS Value | 35.6 |
| IS Momentum | 48.5 |
| IS Safety | 76.8 |
| IS Quality | 42.2 |
| Altman Z-Score | 25.58 |
| Piotroski F-Score | 2.86 |
| Beneish M-Score | -74.30 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Buyback Yield | 0.29% |
| Total Shareholder Return | -27.94% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.659 |
| Earnings Stability | 0.588 |
| Earnings Persistence | 0.745 |
| Margin Stability | 0.278 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -6.63 |
| Median P/B | 3.44 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 95.80% |
| Holdings Matched | 125 |
| Total Holdings | 129 |